Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Lymphoma 178Lymphoma, Large B-Cell, Diffuse 172Precursor Cell Lymphoblastic Leukemia-Lymphoma 88Lymphoma, Follicular 79Lymphoma, Non-Hodgkin 73Burkitt Lymphoma 66Hodgkin Disease 45Leukemia 44Lymphoma, Mantle-Cell 41Lymphoma, T-Cell, Peripheral 31Lymphoma, B-Cell 30Lymphoma, B-Cell, Marginal Zone 28Lymphoma, Large-Cell, Anaplastic 26Lymphoma, Large-Cell, Immunoblastic 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Recurrence 15Immunoblastic Lymphadenopathy 15Neoplasms 14Lymphoma, T-Cell 14Dendritic Cell Sarcoma, Interdigitating 13Waldenstrom Macroglobulinemia 9Multiple Myeloma 9Blast Crisis 8Myelodysplastic Syndromes 7Lymphoma, T-Cell, Cutaneous 7Leukemia, Biphenotypic, Acute 7Enteropathy-Associated T-Cell Lymphoma 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 6

Interventions

blinatumomab 16Cyclophosphamide 15fludarabine phosphate 8fludarabine 8Methotrexate 7Cytarabine 7Rituximab 6Vincristine 5Mercaptopurine 5Melphalan 4Daunorubicin 4obinutuzumab 3Whole-Body Irradiation 3Immunotherapy, Adoptive 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Doxorubicin 3Dexamethasone 3Asparaginase 3tisagenlecleucel 2thymoglobulin 2pegaspargase 2Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Radiotherapy 2Prednisone 2Prednisolone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × Prednisone × Lymphoid × Clear all
NCT05959720 2025-05-07

BRALLA

Instituto do Cancer do Estado de São Paulo

Recruiting
180 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

PETHEMA Foundation

Phase 4 Completed
150 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡